Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Alvarez

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Plant Cell|December 21, 2004
Cross talk between gibberellin and cytokinin: the Arabidopsis GA response inhibitor SPINDLY plays a positive role in cytokinin signalingYaarit Greenboim-Wainberg, Inbar Maymon, Roy Borochov, et al.
Texas Heart Institute Journal|August 2, 2006
Prosthesis replacement in a calcified mitral annulus with reconstruction of the intervalvular fibrous body: the value of an alternative repairIgor E Konstantinov, Martin Carter, Pankaj Saxena, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 13, 2011
Multimodal biomarker investigation on efficacy and mechanism of action for the mammalian target of rapamycin inhibitor, temsirolimus, in a preclinical mammary carcinoma OncoMouse model: a translational medicine study in support for early clinical developmentXinkang Wang, Yutian Zhan, Lei Zhao, et al.
Current Biology : CB|October 17, 2003
Radial patterning of Arabidopsis shoots by class III HD-ZIP and KANADI genesJohn F Emery, Sandra K Floyd, John Alvarez, et al.
Plos One|April 14, 2018
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturationJoanne K Gardner, Scott M J Cornwall, Arthur W Musk, et al.
Translational Oncology|January 5, 2021
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformationBrendan P Hodkinson, Michael Schaffer, Joshua D Brody, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerationsKevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer|November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationGiuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Arthritis Research & Therapy|May 4, 2018
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosusSuzanne Cole, Alice Walsh, Xuefeng Yin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Invasive Brain Mapping Identifies Personalized Therapeutic Neuromodulation Targets for Obsessive-Compulsive DisorderA Moses Lee, Audrey Kist, John Alvarez, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Plant Cell|December 21, 2004
Cross talk between gibberellin and cytokinin: the Arabidopsis GA response inhibitor SPINDLY plays a positive role in cytokinin signalingYaarit Greenboim-Wainberg, Inbar Maymon, Roy Borochov, et al.
Texas Heart Institute Journal|August 2, 2006
Prosthesis replacement in a calcified mitral annulus with reconstruction of the intervalvular fibrous body: the value of an alternative repairIgor E Konstantinov, Martin Carter, Pankaj Saxena, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 13, 2011
Multimodal biomarker investigation on efficacy and mechanism of action for the mammalian target of rapamycin inhibitor, temsirolimus, in a preclinical mammary carcinoma OncoMouse model: a translational medicine study in support for early clinical developmentXinkang Wang, Yutian Zhan, Lei Zhao, et al.
Current Biology : CB|October 17, 2003
Radial patterning of Arabidopsis shoots by class III HD-ZIP and KANADI genesJohn F Emery, Sandra K Floyd, John Alvarez, et al.
Plos One|April 14, 2018
Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturationJoanne K Gardner, Scott M J Cornwall, Arthur W Musk, et al.
Translational Oncology|January 5, 2021
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformationBrendan P Hodkinson, Michael Schaffer, Joshua D Brody, et al.
Journal for Immunotherapy of Cancer|November 29, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerationsKevin K Dobbin, Alessandra Cesano, John Alvarez, et al.
Journal for Immunotherapy of Cancer|November 30, 2016
Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationGiuseppe V Masucci, Alessandra Cesano, Rachael Hawtin, et al.
Arthritis Research & Therapy|May 4, 2018
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosusSuzanne Cole, Alice Walsh, Xuefeng Yin, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2025
Invasive Brain Mapping Identifies Personalized Therapeutic Neuromodulation Targets for Obsessive-Compulsive DisorderA Moses Lee, Audrey Kist, John Alvarez, et al.
Pageof 3